Incidence of testicular germ-cell malignancies in England and Wales: trends in children compared with adults. by dos Santos Silva, I et al.
dos Santos Silva, I; Swerdlow, AJ; Stiller, CA; Reid, A (1999) In-
cidence of testicular germ-cell malignancies in England and Wales:
trends in children compared with adults. International journal of can-
cer, 83 (5). pp. 630-634. ISSN 0020-7136 DOI: https://www.doi.org/10.1002/(sici)1097-
0215(19991126)83:5¡630::aid-ijc11¿3.0.co;2-m
Downloaded from: http://researchonline.lshtm.ac.uk/4647623/
DOI: https://www.doi.org/10.1002/(sici)1097-0215(19991126)83:5¡630::aid-ijc11¿3.0.co;2-
m
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Copyright the publishers

INCIDENCE OF TESTICULAR GERM-CELL MALIGNANCIES IN ENGLAND AND
WALES: TRENDS IN CHILDREN COMPARED WITH ADULTS
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1Cancer and Public Health Unit, London School of Hygiene and Tropical Medicine, London, UK
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The incidence of testicular cancer has been increasing
markedly in most industrialised countries. This rise is known
to have affected young adults, but it is less clear whether it has
affected other age groups, particularly children. We used
data from the National Cancer Registry file at the Office of
National Statistics (ONS) and the National Registry of Child-
hood Tumours to examine trends in testicular germ-cell
malignancies overall in England and Wales from 1962 to 1990
and in children from 1962 to 1995. The incidence of testicular
cancer at all ages rose by 3.4% (95% CI 3.3–3.6%) per annum
from 1962 to 1990. A similar rise in the incidence of germ-cell
malignancies occurred during the years for which histological
information was available in the ONS files, 1971–1989 (3.4%;
3.1–3.6%), to which both seminomas and non-seminomas
contributed equally. The incidence of non-seminomas in
adults rose in men under age 55 years and declined in older
men, whereas there were increases in the incidence of
seminomas in both young and older men. Cohort analysis at
young ages showed a marked rise in the risk of germ-cell
malignancies up to the cohort born in 1955–1959 but no
further rise for those born subsequently. The rise in the
incidence of these tumours in young adults was paralleled by a
similar trend, although less marked, in children aged under 15
years (1.3% per annum; 0.2–2.5%). The increase in risk for
children in this very large data set alongside the rise in young
adults is compatible with the hypothesis that childhood and
adult testicular germ-cell malignancies may have some com-
mon risk factors, presumably pre-natal. Int. J. Cancer 83:630–
634, 1999.
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The incidence of testicular cancer has been increasing during this
century in most industrialised countries, and it is now the most
common malignancy in young men (Swerdlow et al., 1998). Most
testicular cancers are of germ-cell origin (Pike et al., 1987), which
comprises 2 distinct groups: seminomas and non-seminomas. This
latter group comprises several different cell types named differently
according to various classification systems (Teppo, 1973); it is
mainly equivalent to teratomas in the British system. In the
England and Wales National Cancer Registry files, which cover a
large population of about 50 3 106, testicular tumours are coded
according to both site and histology, but the histological data
appear not to have been analysed previously. We used data from
these files to examine recent trends in these tumours and, in
particular, to assess whether the rises in incidence of testicular
cancer at young adult ages have affected similarly its 2 major
histological groups.
The rise in the incidence of germ-cell malignancies is known to
have affected young adults, but it is less clear whether it has
occurred in other age groups, particularly in children. Although the
large majority of testicular cancers in children are of germ-cell
origin, the main histological types are different from those in
adults, with a predominance of yolk-sac tumours. The few studies
that have examined trends in children tended to have been based on
relatively small numbers of tumours (Schottenfeld et al., 1980;
Swerdlow et al., 1982; Møller et al., 1995), and most were not able
to examine separately the trend for tumours of germ-cell origin
(Schottenfeld et al., 1980; Møller et al., 1995). We have extracted
data on malignant testicular germ-cell tumours in children in
England and Wales from the National Registry of Childhood
Tumours, to assess whether the recent increases in testicular
germ-cell incidence in young adults may have also affected
children.
MATERIAL AND METHODS
ONS data
Data on cancers of the testis (ICD7, 178; ICD8-9, 186) (WHO,
1957, 1967, 1977) incident 1962 to 1989 were extracted from the
national cancer registry files at the Office for National Statistics
(ONS). Tumour histology in these files was coded according to the
Manual of Tumour Nomenclature and Coding (MOTNAC) (Ameri-
can Cancer Society, 1951) for 1971 to 1978 data and the Interna-
tional Classification of Diseases for Oncology (ICD-O) (WHO,
1976) for data from 1979 onward. The histological code used
before 1971, a 2-digit OPCS code, was very elementary. Data for
the year 1990 were extracted from a published source (ONS, 1997),
which does not contain information on histology. Therefore, we
examined overall testicular cancer incidence for the years 1962 to
1990 but conducted analyses by histology only for 1971 to 1989.
Mid-year population estimates of England and Wales for 1962 to
1995 were also extracted from the ONS files.
Analyses were carried out for testicular germ-cell cancers
overall and separately for their 2 major histological categories:
1) seminomas and 2) non-seminomas, including both embryonal
and extra-embryonal cell types (i.e., embryonal cell carcinoma,
endodermal sinus tumour and choriocarcinoma). Mixed tumours
with seminomatous elements were allocated to non-seminomas.
Since data on histological type were incomplete in the ONS files,
the observed numbers of testicular cancers with germ-cell histol-
ogy in these files constitute an under-estimation of the true numbers
of incident cases, and the extent of this under-estimation will have
varied by time and age. The true numbers were therefore estimated
by multiplying, in each year of registration and 5-year age group,
the observed number of registrations by the inverse of the
corresponding proportion of testicular cancers with histological
confirmation. The analyses presented here are for tumours of
known histology, unless otherwise stated; but we also repeated
them, adjusting for tumours of unknown histology. However, the
proportion of testicular tumours with known histology was very
high (about 94% nationally, see ‘‘Results’’); therefore, these
adjustments made little difference to the findings.
CCRG data
We also extracted data from the National Registry of Childhood
Tumours at the Childhood Cancer Research Group (CCRG). This
registry collects data on all incident cancers diagnosed in children
resident in the country and aged under 15 years. Tumours are
ascertained from the regional cancer registries, local population-
based childhood cancer registries and the register of patients treated
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by members of the UK Children’s Cancer Study Group (UKCCSG).
The registry also receives death certificates of all deaths occurring
in Britain under the age of 20 and with a neoplasm coded as the
underlying cause. As a result, the Group’s register is particularly
complete. We extracted from its files data on all testicular germ-cell
malignancies incident in England and Wales during 1962–1995.
Analysis of time trends
Direct age-standardised incidence rates by single year of age
were calculated using the 1971 mid-year male population of
England and Wales as the standard. To assess secular trends, a
Poisson regression model was fitted (Breslow and Day, 1987). For
the ONS data adjusted for incompleteness of histological informa-
tion, the estimated numbers of incident cases were truncated to
whole numbers before the model was fitted.
To examine risks according to birth cohort, standardised cohort
incidence ratios (SCIRs) were calculated by the indirect method,
using the average age-specific rates for the entire period to derive
the expected values for each cohort. These analyses were carried
out by 5-year periods of birth. Since the cancer registry files
contained information on the exact year of birth of the cancer cases,
we also conducted more detailed analyses by single year of birth to
examine possible sudden cohort changes in risk due to short-term
changes in exposure levels (e.g., changes in maternal diet during
World War II).
RESULTS
A total of 23,393 testicular cancers were included in the ONS
cancer registry files for 1962–1990. For the years for which
histological information was available (1971–1989), there were
17,215 testicular tumours after exclusion of 49 lymphoma and
Hodgkin’s disease registrations that were erroneously coded as
testicular cancers (WHO, 1977). Germ-cell tumours represented
97% (n 5 15,763) of all testicular cancers of known histology:
55.2% (n 5 8,703) of these germ-cell tumours were seminomas
and 44.8% (n 5 7,060) non-seminomas.
Ninety-four percent of testicular cancers in the ONS data set
were of known histology. However, this percentage varied by age:
it was 95% at ages under 65 years but only 76% at ages 65 and over.
There was little change in the overall percentage of histologically
confirmed testicular cancers over time.
Age distributions by single year for the 2 major types of
germ-cell tumour in adults are shown in Figure 1. Non-seminomas
started to rise at age 13 and peaked around age 27, whereas
seminomas began to increase and peaked some years later (at ages
16 and 34, respectively). As a result, non-seminoma was the most
common histology at ages under 30 and seminoma at older ages.
A total of 298 testicular malignant germ-cell tumours in England
and Wales were incident in children under age 15 during 1962–
1995. The large majority of these were non-seminomas, with 76%
(n 5 225) being of yolk-sac origin and 21% (n 5 62) teratomas.
There were only 9 seminomas at these ages and 2 cases of
unspecified germ-cell origin. Analysis by single year of age showed
a peak at ages under 3, which differed for yolk-sac tumours and
teratomas. For yolk-sac tumours, rates peaked in the second year of
life and decreased thereafter, whereas for teratomas the maximum
occurred in the first year of life with rates falling thereafter until
they started to rise again at age 13 (the very beginning of the steep
rise through adolescence and young adulthood).
There was a statistically significant increase in the risk of
testicular cancer overall from 1962 to 1990 [mean annual percent
change in rates 5 3.4%, 95% confidence interval (CI) 3.3–3.6%;
p , 0.001; Fig. 2]. This increase was much more marked at ages
under 55 years (3.7%, 3.5–3.9%; p , 0.001) than at ages 55 years
and above (1.2%, 0.7–1.7%; p , 0.001). Analyses of testicular
cancer trends by histology were possible only for 1971–1989 (see
‘‘Material and Methods’’). For these years, there was an increase in
the overall incidence of germ-cell tumours, to which both semino-
mas and non-seminomas contributed equally (Table I). Similar
results were obtained after adjusting for tumours of unknown
histology. However, analyses by age showed diverging time trends
in the incidence of non-seminomas for young and older men (Table
I): at ages 0–54 there was a significant increase in the incidence of
these tumours, whereas at older ages there was a decline. In
contrast, the incidence of seminomas increased in both age groups,
though more markedly at young than at older ages (Table I).
Overall, the incidence of germ-cell tumours increased in young, but
not in older, men (Table I). These analyses were unadjusted for
cases of unknown histology, but adjusting for this gave similar
results.
Further breakdown by 5-year age group showed mean annual
percent increases in the incidence of non-seminomas in all age
groups from 15 to 54 years but annual declines at older ages. For
seminomas, the increase affected all age groups from 15 to 74
years; there was little change in risk at ages 75 and older, but this
was based on a smaller number of cases. The mean annual percent
increases in the incidence of germ-cell tumours at ages 15–19,
20–24 and 25–34 years were 2.1% (0.6–3.7%), 2.8% (2.0–3.7%)
and 2.9% (2.4–3.4%), respectively. There were no statistically
significant changes in risk at ages under 15 years, but the 95% CIs
were wide because of small numbers. At age 0–4, when the large
majority of childhood germ-cell tumours occurred, there was a near
significant increase (2.6%, 20.29–5.6%; p 5 0.08).
Cohort analyses showed that the risk of testicular cancer at ages
under 55 years remained relatively constant for men born from
FIGURE 1 – Age-specific incidence rates of testicular germ-cell
malignancies by single year of age, England and Wales, 1971–1989.
FIGURE 2 – Secular trends in the incidence of testicular cancer of all
histological types combined by age, England and Wales, 1962–1990.
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1911 to 1935, increased for those born from 1935 to 1957 but
stabilized again for those born subsequently [the SCIRs for all
germ-cell malignancies combined for cohorts born in 1955–1959
and 1965–1969 were 114 (95% CI 109–118) and 106 (97–106),
respectively] (Fig. 3). The rise was relative steady, with no obvious
dips or peaks (apart from small random fluctuations) (Fig. 3a). In
particular, there was no decrease in risk for men born during World
War II. At older ages (not shown), the risk remained relatively
constant for successive generations except for a slight increase for
the last generations in these analyses (born 1920–1930). The cohort
increase at young ages was similar for non-seminomas and
seminomas (Fig. 3b). At ages 55 and over (not shown), there was a
marked decline in the risk of developing a non-seminoma for
successive generations of men born since the turn of the century but
no clear trend for seminoma except for an increase in risk for the 2
most recent generations in these analyses. Similar results were
obtained with the data adjusted for cases of unknown histology.
Analyses of secular trends in children under 15 years of age
revealed an overall increase in the incidence of malignant germ-cell
tumours during the years 1962–1995, entirely due to a rise in
yolk-sac tumours (Table II). The 5-year age-specific trends were
more difficult to interpret because of the small number of cases,
particularly at ages 5–9. At ages 0–4, there was a rise in risk, but it
was not statistically significant; however, the trends diverged by
cell type, with a statistically significant rise in yolk-sac tumours
and a significant decline in teratomas (Table II). At ages 10–14, the
data were consistent with a rise in incidence but the 95% CIs were
wide (Table II).
DISCUSSION
Our results show that the incidence of testicular cancer overall
has increased markedly since 1962. The trends were different for
the 2 main adult age groups, however, resulting from differences by
age for non-seminoma: a rise in incidence in young men and a
decline in older men. Analysis by birth cohort also implied an
increasing risk of non-seminomas for successive generations of
men at ages under 55 and a decline at older ages. In contrast, there
were increases in the incidence of seminomas in young and older
men. Similar increases in testicular cancer incidence at young ages
with cohort effects underlying them have been shown in other
studies (e.g., Schottenfeld et al., 1980; Brown et al., 1986;
Østerlind, 1986; Bergstro¨m et al., 1996; Zheng et al., 1996; Weir et
al., 1999). In those studies that presented analyses by cell type
(e.g., Brown et al., 1986; Østerlind, 1986; Zheng et al., 1996; Weir
et al., 1999), as in the present study, the rise in incidence at young
ages affected seminomas and non-seminomas to the same degree,
suggesting that they may be of similar aetiology. The cohort data
presented here appear to indicate that risks have stabilised in the
most recent cohorts, a trend seen also in Scotland (Swerdlow et al.,
1998). In contrast, the rise in the incidence of testicular cancer at
old ages observed in the present study, which was entirely due to
seminomas, has not been shown in other studies (e.g., Brown et al.,
1986; Østerlind, 1986; Zheng et al., 1996).
The completeness of the England and Wales national cancer
registration scheme has probably not altered appreciably since
1971 (Swerdlow et al., 1993). Therefore, although improved
completeness could have accounted, at least in part, for the rises of
testicular cancer in the 1960s, it is unlikely to do so for more recent
years. Potential late registrations, yet to be entered into the national
cancer registry files, are likely to have been of negligible effect as
the analyses were conducted only to 1990 using data extracted from
ONS files several years later. Incompleteness of histological
confirmation also is unlikely as an explanation for the findings as
the proportion of cancers with unknown histology was small. This
was particularly true at younger ages, when most of the tumours
FIGURE 3 – Trends in incidence of testicular cancer by birth cohort.
(a) Analyses by single year of birth for all histological types combined
among men aged 0–54 years, England and Wales, 1962–1990. (b)
Five-year cohort analyses by histological type among men aged 0–54
years, England and Wales, 1971–1989.
TABLE I – TRENDS IN INCIDENCE OF GERM-CELL MALIGNANCY OF THE TESTIS BY AGE AND HISTOLOGY: ENGLAND
AND WALES, 1971–1989
Age
(years) Histological type
Rate Mean annual percent
change in rate (95% CI),
1971–1989
p value
1971–19751 1986–19891
0–54 Seminomas 16.0 25.1 3.7 (3.3–4.1) ,0.001
Non-seminomas 14.6 22.2 3.6 (3.1–3.9) ,0.001
All germ cell tumours 30.6 47.2 3.7 (3.5–3.9) ,0.001
551 Seminomas 10.3 12.0 1.6 (0.5–2.7) ,0.001
Non-seminomas 3.6 2.1 22.9 (25.0 to 20.9) 0.006
All germ cell tumours 13.9 14.1 0.6 (20.3–1.6) 0.18
All ages Seminomas 14.8 22.2 3.4 (3.0–3.8) ,0.001
Non-seminomas 12.1 17.7 3.4 (2.9–3.8) ,0.001
All germ cell tumours 26.9 39.9 3.4 (3.1–3.6) ,0.001
1Rates (per 106) age-standardised by single year to the 1971 England and Wales male population.
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occurred. Moreover, similar results were obtained when the
analysis was adjusted for tumours of unknown histology, though
the method used assumed a similar degree of incompleteness for
the various histological types. Lack of uniform criteria among
pathologists and potential changes in diagnostic criteria over time
might have affected the histology-specific results. However, the
age-distribution curves from the present data were similar to those
from another registry-based study in which histology was specially
reviewed (Pike et al., 1987). A review of the histology of all
testicular tumours registered in the state of Victoria (Australia)
during 1950–1978 made no difference to the histology-specific
trends (Stone et al., 1992).
In the present study, the increase in the incidence of testicular
germ-cell tumours in young adults was paralleled by a trend in the
same direction (although of smaller magnitude) in children under
15 years. This included a rise at ages 0–4 years, when the large
majority of childhood germ-cell tumours occurred, though this was
not statistically significant; the diverging trends by cell type at
these ages are likely to be the result of time changes in nomencla-
ture and coding practices. The trend at ages 10–14 was also
consistent with a possible rise in risk and corresponds to the initial
tail of the young adult peak. Relatively few studies have examined
trends in children. No rises in the risk of childhood testicular
cancers were observed in Connecticut from 1935 to 1976 (Schotten-
feld et al., 1980) or Denmark from 1943 to 1982 (Østerlind, 1986),
but both of these studies were based on small numbers of cases.
More recently, no statistically significant increases in the incidence
of testicular cancer at ages 0–4 and 5–14 were found in the
combined data from 3 Nordic countries (Denmark, Norway and
Sweden) during 1958–1987 (Møller et al., 1995), but the confi-
dence interval was again very wide and consistent with a possible
rise in risk. Moreover, in none of these studies were trends
examined separately for testicular cancers of germ-cell origin. In
contrast, a rapid increase in testicular cancer mortality in children,
presumably reflecting a similar trend in the incidence of these
tumours, was observed in Japan during 1947–1970 (Lee et al.,
1973).
The fact that the trends in young adults and children were in the
same direction suggest that childhood and adult germ-cell tumours
may have common risk factors and that these are likely to be of
pre-natal origin (Henderson et al., 1982). Undescended testes and
other developmental urogenital abnormalities are the only well-
established risk factors for testicular cancer in both adults (UK
Testicular Cancer Study Group, 1994) and children (Li and
Fraumeni, 1972; Swerdlow et al., 1982). Although the apparent
incidence of these conditions is rising (John Radcliffe Hospital
Cryptorchidism Study Group, 1986), they are too uncommon to
account for the entire rise in the risk of testicular cancers. There is
evidence that the increase in incidence of disorders of the male
reproductive tract in the last decades has been paralleled by a
decline in semen quality (Carlsen et al., 1992), though this has been
disputed (Bromwich et al., 1994). Results from a recent population-
based case-control study showed that paternity was associated with
a decrease in the risk of subsequent testicular cancer, a finding
which was regarded by the authors as being consistent with the
hypothesis that male subfertility and testicular cancer may have
some common risk factors (Møller and Skakkebaek, 1999). It has
been proposed that all of these male reproductive abnormalities
might be related to exposure to increased levels of endogenous and
exogenous oestrogens during the first trimester of pregnancy, when
the testis is being formed (Henderson et al., 1982; Depue et al.,
1983; Sharpe and Skakkebaek, 1993).
Indirect evidence to support the hypothesis that pre-natal expo-
sures may be important in the aetiology of testicular cancer comes
from the fact that men who were born or were young boys during
World War II in Denmark, Norway and Sweden had a lower risk of
testicular cancer than previous and subsequent generations (Berg-
stro¨m et al., 1996). The decline in risk for men born during the war
years may be related to changes in diet and other lifestyle variables
that may have affected oestrogen levels in the mother. Paradoxi-
cally, there was no similar decline in risk for generations born
during World War II in Poland, the former East Germany and
Finland, which may have been as affected or more so by the war
than the other Nordic countries (Bergstro¨m et al., 1996). In the
present study, SCIRs were calculated by single year of birth to
make it easier to unveil the effect of any short-term changes in
exposure levels. Despite this, we did not find any fall in the risk of
testicular cancer for generations born in England and Wales during
World War II. Similarly, no decline was observed in Scotland
(Swerdlow et al., 1998). Although there were marked changes in
the British diet during the war years, the levels of caloric intake
never dropped as much as in the Nordic countries and the diet of
pregnant women on the whole might even have improved. National
distribution of free and cheap milk was implemented for expectant
mothers in the 1930 and 1940s (MAFF, 1951). In interpreting the
observed SCIRs it is important to keep in mind that because the
overall (all years) data had to be used to calculate the expected
values, the ratio of observed to expected will tend to be conserva-
tively biased, particularly in the earliest and latest cohorts; there-
fore, real changes might have been under-estimated. Interpretation
should also take into account that the experience for the most recent
generations was based only on the (young) age groups that they
have reached so far.
Post-natal factors may also have contributed to the observed rise
in the incidence of testicular germ-cell malignancies at young adult
ages and account, at least in part, for the fact that the increase was
more marked at these ages than in children. Although the rise in the
incidence of testicular cancer has been paralleled by a trend
towards an earlier age at puberty, the evidence from analytic studies
on the relation to age at puberty has been largely inconsistent.
Some studies (Moss et al., 1986; UK Testicular Cancer Study
Group, 1994), but not all (Depue et al., 1983; Swerdlow et al.,
TABLE II – TRENDS IN THE INCIDENCE OF GERM CELL MALIGNANCIES OF THE TESTIS IN BOYS AGED UNDER 15
YEARS BY AGE AND HISTOLOGY, ENGLAND AND WALES, 1962–95
Age
(years) Histological type (n)
Rate Mean annual percent
change in rate (95% CI),
1962–1995
p value
1962–701 1986–951
0–4 Yolk sac (214) 2.32 3.66 1.7 (0.4–3.1) 0.01
Teratoma (31) 0.89 0.45 24.0 (27.6 to 20.4) 0.03
All germ cell (247) 3.26 4.16 1.0 (20.3–2.2) 0.13
5–9 All germ cell2 (13) 0.12 0.12 21.3 (26.1–3.6) 0.56
10–14 All germ cell2 (38) 0.31 1.01 4.1 (21.2–9.6) 0.13
All Yolk sac (225) 0.81 1.30 1.7 (0.4–3.0) 0.01
Teratoma (62) 0.04 0.05 20.3 (22.8–2.2) 0.80
All germ cell (298) 1.24 1.77 1.3 (0.2–2.5) 0.02
1Rates (per 106) age-standardised by single year to the 1971 England and Wales male popula-
tion.–2Analyses by cell type were not carried out because of the small number of cases in these age groups.
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1989; Gallagher et al., 1995), have found an association with an
early age of puberty. Another analysis found reduced risk for late
puberty but not raised risk for early puberty (Møller and Skakke-
baek, 1996). The increased risk of testicular cancer in tall men
found in some studies (Gallagher et al., 1995; Swerdlow et al.,
1989) suggests that nutrition and growth before puberty may also
be important aetiological factors. Adult height has been increasing
through the century (Floud et al., 1990), and this trend could
potentially be related to the rise in the incidence of testicular cancer
in young adults. The finding of Møller et al. (1995) that the secular
increase in the incidence of testicular cancer was particularly
marked in boys aged 15–19 years would be consistent with a
possible role of peri-pubertal factors on the aetiology of this cancer.
No similar finding was observed in our present study.
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